Seeking Alpha

NGSX
NeurogesX, Inc. - OTCPK - No Info

4/20/2014, 7:07 AM ET
Quote & Analysis Breaking News StockTalk
ngsx chart
Today 5d 1m 3m 1y 5y 10y
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
FOCUS  |  RELATED  |  TRANSCRIPTS  |  OTHER NEWS & PR
OTHER NEWS
NGSX vs. ETF Alternatives
Company Description

NeurogesX, Inc. is a specialty pharmaceutical company focused on developing and commercializing a portfolio of novel non-opioid, pain management therapies to address unmet medical needs and improve patients' quality of life.

The Company's lead product, Qutenza?, is currently approved... More